Business Description
Relmada Therapeutics is a US-based biotech company focused on developing new treatments for serious medical conditions. Its two lead programs include a bladder cancer therapy currently in Phase 2 trials and a compound targeting neurological disorders such as Prader-Willi syndrome and Tourette syndrome, which is nearing its next stage of clinical testing. The company works alongside partners Asarina Pharma AB and Trigone to advance these efforts. Founded in 2004, Relmada is headquartered in Coral Gables, Florida.
